Study of Entospletinib (ENTO) in Newly Diagnosed DLBCL Patients With aaIPI>=1 Treated by Chemiotherapy
Clinical trial NCT03225924 · TERMINATED
Trial details
- NCT number
- NCT03225924
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-26
- Primary completion
- 2019-10-18
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.